74SOFTWARE 39.200 € (+0,77 %)
FDJ UNITED 22.300 € (+0,68 %)
TONNER DRONES 0.028 € (-1,05 %)
LIGHTON 3.940 € (+2,20 %)
EXOSENS 60.250 € (-1,15 %)
PULLUP ENTERTAIN 8.270 € (+0,98 %)
AIRBUS 203.450 € (-0,12 %)
THALES 252.400 € (-0,28 %)
SODEXO 56.450 € (+0,36 %)
BOLLORE 3.812 € (-0,68 %)
HERMES INTL 1 577.500 € (+0,29 %)
CARREFOUR 15.910 € (+0,25 %)
ASR NEDERLAND 69.460 € (0,00 %)
SHELL PLC 39.975 € (+0,16 %)
ELEC.STRASBOURG 165.800 € (+0,73 %)
COFACE 15.910 € (+0,25 %)
PROACTIS SA 0.067 € (-8,84 %)
SES 4.886 € (-0,73 %)
ABIVAX 99.300 € (-2,46 %)
BIOPHYTIS 0.089 € (-14,95 %)
STMICROELECTRONICS 42.790 € (-0,67 %)
LEGRAND 133.750 € (-0,67 %)
KERING 255.550 € (+0,49 %)
ASM INTERNATIONAL 824.800 € (-0,67 %)
RELX 30.640 € (-0,07 %)
SIRIUS MEDIA 0.501 € (-8,22 %)
CELLECTIS 2.854 € (-0,56 %)
SANOFI 78.620 € (-0,41 %)
ASML HOLDING 1 493.200 € (-0,85 %)
AEGON 7.760 € (+0,05 %)
VALERIO TX 0.758 € (-10,82 %)
TOMTOM 4.052 € (-0,54 %)
WOLTERS KLUWER 70.960 € (-0,37 %)
ADVICENNE 1.820 € (+3,88 %)
TME PHARMA 0.114 € (+28,03 %)
MAGNUM 17.072 € (+0,52 %)
LVMH 452.000 € (-0,11 %)
ARCELORMITTAL SA 62.260 € (-0,51 %)
VETOQUINOL 70.500 € (0,00 %)
FUGRO 8.950 € (-0,61 %)
PROSUS 37.310 € (-2,57 %)
SCHNEIDER ELECTRIC 295.300 € (-0,51 %)
CAPGEMINI 110.400 € (-0,67 %)
NANOBIOTIX 36.340 € (-4,47 %)
QUADIENT 12.740 € (+3,75 %)
2CRSI 26.700 € (+0,23 %)
CSG 18.394 € (-0,48 %)
BNP PARIBAS ACT.A 107.260 € (-0,22 %)
STELLANTIS NV 4.515 € (-2,88 %)
AXA 43.790 € (+0,16 %)
AHOLD DEL 31.140 € (+0,32 %)
ICADE 19.010 € (+0,16 %)
BE SEMICONDUCTOR 210.700 € (-0,99 %)
TOTALENERGIES 77.190 € (-0,32 %)
INTRASENSE 0.440 € (+15,79 %)
AYVENS 11.390 € (-0,35 %)
ESSILORLUXOTTICA 162.250 € (-0,58 %)
OSE IMMUNO 3.300 € (-1,02 %)
ADYEN 1 075.200 € (+0,11 %)
MERCIALYS 11.320 € (+0,18 %) |
24/08/2026 06:31
Metall Zug – results for the first half of 2026Metall Zug AG / Key word(s): Half Year Results Ad hoc announcement pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Zug, August 24, 2026 – Metall Zug (SIX: METN) announces result for the first half of 2026
Metall Zug Group Metall Zug made tangible operational progress in the first half of 2026. All of the operational Business Units reported strong business performance and achieved growth. The group benefited from the continued implementation of measures to improve profitability. Thanks to higher efficiency and an adjusted cost base the trading operating result (EBIT before result from strategic investments) returned to break-even despite negative currency effects, US tariffs, and a continued challenging market environment.
The improvement was particularly evident at Haag-Streit. The Medical Devices Business Unit was able to increase sales and take advantage of rising unit volumes in its core business of slit lamps. Thanks to structural changes and the further reduction in the cost base – particularly in research and development – the Business Unit returned to profitability. Following extensive investments in research and development in recent years, Haag-Streit is significantly modernizing its product portfolio to lay the basis for future growth.
The Tech Cluster Zug generational project also made considerable progress. SHL Medical became the first third-party industrial user to move to the site alongside V-ZUG. The planned ETH Learning Factory Zug is still going through the political process, which is expected to be finalized in January 2027. The aim of this generational project is to create a forward-looking environment on the site that closely intertwines industry, research, education, commerce, and housing.
The reported net sales of the Metall Zug Group rose slightly to CHF 95.6 million (previous year: CHF 94.2 million). This was impacted by negative currency effects, particularly the weaker US dollar. Adjusted for currency effects, this resulted in organic growth of 5.5%. The operating result of the directly controlled Business Units returned to profitability at CHF 2.3 million, substantially above the prior-year figure of CHF –7.4 million. EBIT improved to CHF –3.7 million, compared to CHF –12.6 million in the prior year. This figure includes the proportionate results from the strategic investments of CHF –6.0 million (previous year: CHF –5.1 million).
The net result came to CHF –4.4 million (previous year: CHF –10.3 million), and cash flow from operating activities stood at CHF 7.4 million, significantly exceeding the prior-year level of CHF –5.4 million. As at June 30, 2026, the Metall Zug Group has an equity ratio of 65.0% (December 31, 2025: 67.4%) and therefore maintains a solid financial base. The slight decline is associated with the increase in debt financing used for the ongoing real estate projects at Tech Cluster Zug.
WEMACO Invest AG, as the third-largest shareholder of Metall Zug AG, sold its stake of around 11% (share of capital) in Metall Zug in June 2026 following a generational change. Metall Zug supported the placement of the share package, with a significant portion being acquired by members of the Board of Directors and the Senior Management of Metall Zug AG, as well as by members of the Senior Management of the Business Units.
Medical Devices Business Unit – Haag-Streit Group
HY 1 2026
HY 1 2025
Δ CHF million
Net sales
78.2
77.1
1.5% Operating result (EBIT)
2.7
-2.6
202.8% EBIT margin in %
3.5
-3.4
690bp
Research & Development (R&D)
-9.6
-12.6
-24.1% Operating result (EBIT) excl. R&D
12.3
10.0
23.0% EBIT margin excl. R&D in %
15.7
13.0
270bp
The Medical Devices Business Unit (Haag-Streit Group) generated net sales of CHF 78.2 million in the first half of 2026, which was slightly above the prior-year level of CHF 77.1 million despite negative currency effects of 5.0%. Adjusted for currency effects, this resulted in organic growth of 6.5%. This solid growth was driven in particular by the core business of slit lamps, where sales volumes increased by more than 20%. The newly introduced Elara 900 hybrid digital slit lamp saw encouraging demand, but established models also performed well, particularly in the US market. In addition, the high-margin Simulation product area posted rising sales figures, and the METIS 900 surgical microscope is meeting with a good market response. This positive performance was achieved despite a challenging market environment in the medical devices sector. Increased uncertainty in international markets led to cautious investment activity, particularly in Asia. At the same time, the weakening of foreign currencies against the Swiss franc had a negative impact on the competitiveness of products manufactured primarily in Switzerland, as well as on sales growth in Swiss francs.
Haag-Streit returned to profitability in the first half of 2026 with an EBIT of CHF 2.7 million (previous year: CHF –2.6 million). This was largely due to the measures introduced in 2025 to improve efficiency, the optimized organizational structure, and the sustainable reduction in the cost base. Factors contributing to this decrease included lower R&D expenses, a sharper focus on the development portfolio, and structural changes. In addition, US tariff refunds of CHF 1.3 million had a positive net effect on the result.
After several years of investment in research and development, Haag-Streit launched three entirely new products on the market – the METIS 900, Elara 900, and Refractor 900. Additional product launches in the Perimetry product area are planned for the second half of 2026 and 2027. Haag-Streit’s focus is increasingly shifting toward the successful market introduction of new products and intensified market development.
Technologycluster&Infrastructure Business Unit
HY 1 2026
HY 1 2025
Δ CHF million
Net sales
0.0
0.0
n/a Other operating income
7.1
6.5
8.1% Operating result (EBIT)
2.1
0.8
155.4%
The Tech Cluster Zug generational project continued to take shape in the first half of 2026 – under the leadership of the new CEO Silvan Burkhalter since April. In the first half of 2026, the Technologycluster & Infrastructure Business Unit invested CHF 23.0 million (previous year: CHF 14.7 million) in ongoing projects. The Business Unit generated CHF 7.1 million rental income and income from building contractor services, compared with CHF 6.5 million in the previous year. Thanks to higher rental income, EBIT increased to CHF 2.1 million (previous year: CHF 0.8 million).
The arrival of SHL Medical as the first third-party industrial user on the site alongside V-ZUG was a particular highlight. The production area of the SHL-Südtor building has already been handed over and is gradually being put into service, resulting in first rental income from April 2026 onward. The construction project is scheduled to be completed with the full handover of the office space at the end of 2026. The planned ETH Learning Factory Zug on the Tech Cluster site represents another milestone. It is intended to promote exchange and collaboration between education, research, and industrial practice. The project is still going through the political process, which is expected to be finalized in January 2027.
In March, building construction began on the CreaTower I project, the new headquarters of VZ Depository Bank. The innovative Rippmann-Floor-System (RFS) is being used for the first time – a prefabricated vaulted ceiling structure consisting of thin, double-curved concrete shells with vertical reinforcements, which requires much less concrete than conventional construction methods. With regard to the high-rise project Pi, which is intended to create around 70% of affordable housing, the administrative appeal filed against the development plan was rejected by the Zug cantonal government at first instance in July 2026. The complainant has contested the decision with the administrative court of the Canton of Zug. The pyrolysis plant developed by the Association for the Decarbonization of Industry (VZDI) and its partners on the Tech Cluster site passed its final acceptance test in June 2026 and has now begun test operations. V-ZUG’s enameling furnaces are scheduled to be fired with climate-friendly hydrogen for the first time starting from the first quarter of 2027.
Investments & Corporate The Investments & Corporate reporting segment comprises Metall Zug AG (Corporate), Gehrig Group AG and the strategic investments in V-ZUG (33%), Komax (25%), and SteelcoBelimed (33%). By increasing its stake in V-ZUG Holding AG from 30.3% to 33.3% in June 2026, Metall Zug is underscoring its position as a long-term anchor shareholder and reaffirming its commitment to V-ZUG, as well as to Zug and Switzerland as production locations. This increase was also linked to the aforementioned generational change at WEMACO Invest AG.
HY 1 2026
HY 1 2025
Δ CHF million
Net sales
17.3
17.1
1.0% Operating result (EBIT)
-8.5
-10.8
21.4%
In the first half of 2026, the segment generated net sales of CHF 17.3 million (previous year: CHF 17.1 million) and an EBIT of CHF –8.5 million (previous year: CHF –10.8 million). EBIT includes the proportional results from the strategic investments of CHF –6.0 million (previous year: CHF –5.1 million) and can be broken down as follows:
V-ZUG (33%)
Komax (25%)
SteelcoBelimed (33%)
HY 1 2026
HY 1 2025
HY 1 2026
HY 1 2025
HY 1 2026
HY 1 2025 CHF million
Proportional
2.1
0.5
-1.2
-1.1
-6.9
-4.5
Detailed information on the business performance of V-ZUG and Komax can be found in the half-year reports published by each company. SteelcoBelimed generated net sales of CHF 181.5 million (previous year: CHF 176.5 million) in the first half of the year. Business performance was once again marked by strong seasonality, with a weaker first half of the year. In addition, investments in future growth (service & marketing) as well as extraordinary expenses were incurred in relation to the post-merger integration, which continues to progress. With an EBIT of CHF –22.2 million (previous year: CHF –10.8 million), SteelcoBelimed remained well below the break-even point.
The Gehrig Group posted steady growth in the first half of 2026, generating sales of CHF 17.3 million – slightly higher than the previous year (CHF 17.1 million). Higher sales figures in the thermal appliances and cleaning agents product area had a particularly positive impact. In the service business, the number of long-term maintenance contracts increased, while sales were lower than in the previous year. EBIT remained negative but improved significantly compared with the prior year thanks to structural changes and cost savings in the second half of 2025.
Outlook The Group has a solid foundation for attractive growth opportunities and is confident about the medium- and long-term prospects of its Business Units and strategic investments. At the same time, the economic environment continues to be characterized by heightened volatility and limited visibility. The multitude of global economic, political, and currency-related factors makes it difficult to predict business performance reliably for the remainder of the year.
About the Metall Zug Group
In addition, Metall Zug holds anchor participations in the listed V-ZUG Holding AG (33%), the listed Komax Holding AG (25%) and SteelcoBelimed AG (33%), a joint venture with Miele. The holding company Metall Zug AG is listed in the Swiss Reporting Standard of SIX Swiss Exchange in Zurich (type B registered shares: securities number 3982108, ticker symbol METN). Legal Notes Chief Financial Officer Phone: +41 58 768 60 50 Bettine Killmer Head of Corporate Communications & IR Phone: +41 58 768 60 50 or: investorrelations@metallzug.ch This announcement is available at https://metallzug.ch/en/media and the Half-year Report 2026 and investor presentation at https://metallzug.ch/en/download-centre. Key Figures Metall Zug Group
Balance Sheet
Assets
06.30.26
12.31.25
Liabilities and
06.30.26
12.31.25 CHF million
CHF million
Current assets
148.4
135.0
Current liabilities
52.2
46.5 Of which cash and
16.4
16.1
Non-current liabilities
191.9
171.3 Tangible assets
204.6
192.8
Total liabilities
244.1
217.8 Financial Assets
343.7
337.6
Shareholders' equity
454.1
449.4 Intangible Assets
1.6
1.8
in % of total assets
65.0
67.4 Fixed assets
549.9
532.2
Total assets
698.2
667.2
Total liabilities and
698.2
667.2
Income Statement
HY 1 26
HY 1 25
CHF million
Net sales
95.6
94.2
Trading operating result
2.3
-7.4
in % of net sales
2.4
-7.9
Operating result (EBIT)
-3.7
-12.6
Financial result
-0.2
1.4
Result before taxes
-3.9
-11.2
Net result
-4.4
-10.3
in % of net sales
-4.6
-11.0
Employees (FTE)
869
952
Statement of Cash Flows
HY 1 26
HY 1 25
CHF million
Cash flow from
7.4
-5.4
Cash flow from
-27.8
-27.1
of which investments (w/o financial assets, M&A)
-24.9
-17.6
Cash flow from
21.0
30.6
End of Inside Information 2387140 24-Aug-2026 CET/CEST Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière